ObesiD is an innovative dosing in obesity resource brought to you by Advanced Pharmacy Australia and powered by Therapeutic Guidelines.
In 2022, approximately 32% of Australian adults were living with obesity and a further 34% were overweight. In the last decade, the proportion of adults with obesity has increased.
ObesiD is an Australian-first clinical resource for dosing in patients with obesity. It will offer concise guidance on the principles of dosing in obesity, evidence-based advice for
more than 70 medicines and calculators in a modern digital app experience. This resource is the first of its kind in Australia. Digital access to the platform will support healthcare professionals to
confidently care for patients with obesity. Subscriptions will include desktop and mobile app and are available from March 2026.
